Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for use in Scotland 09/08/2021

Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for use in Scotland Action Bladder Cancer UK are delighted that the Scottish Medicines Consortium have announced today that the immunotherapy Avelumab (Bavencio) has been accepted for use in Scotland. In a phase III study, ma...